All set to welcome you for the next two days at #Edinburgh #ClinicalTrial Management Course! #ECTMC25 @streweek.bsky.social @bleedingstroke.bsky.social @ace-aberdeen.bsky.social @merrij.bsky.social
November 6, 2025 at 8:24 AM
All set to welcome you for the next two days at #Edinburgh #ClinicalTrial Management Course! #ECTMC25 @streweek.bsky.social @bleedingstroke.bsky.social @ace-aberdeen.bsky.social @merrij.bsky.social
Angel and Lee from Clinical Trial.
I want the relationship to work but...*sigh*
Total time spent: 5.2 hours across 3 days.
#pixelart #krita #clinicaltrial #manlybadasshero #fanart
I want the relationship to work but...*sigh*
Total time spent: 5.2 hours across 3 days.
#pixelart #krita #clinicaltrial #manlybadasshero #fanart
October 31, 2025 at 11:08 PM
Angel and Lee from Clinical Trial.
I want the relationship to work but...*sigh*
Total time spent: 5.2 hours across 3 days.
#pixelart #krita #clinicaltrial #manlybadasshero #fanart
I want the relationship to work but...*sigh*
Total time spent: 5.2 hours across 3 days.
#pixelart #krita #clinicaltrial #manlybadasshero #fanart
Dr Sophie Merrick (@drsophiemerrick.bsky.social) presented at #ESMO25 results from her qualitative study within the RAMPART #ClinicalTrial.
Her research highlights how immunotherapy impacts the lives of kidney cancer patients, an essential view in cancer care.
🔗 View the poster: buff.ly/fPtvyZ2
Her research highlights how immunotherapy impacts the lives of kidney cancer patients, an essential view in cancer care.
🔗 View the poster: buff.ly/fPtvyZ2
November 3, 2025 at 11:34 AM
Dr Sophie Merrick (@drsophiemerrick.bsky.social) presented at #ESMO25 results from her qualitative study within the RAMPART #ClinicalTrial.
Her research highlights how immunotherapy impacts the lives of kidney cancer patients, an essential view in cancer care.
🔗 View the poster: buff.ly/fPtvyZ2
Her research highlights how immunotherapy impacts the lives of kidney cancer patients, an essential view in cancer care.
🔗 View the poster: buff.ly/fPtvyZ2
#ESMO25: #ctDNA has emerged as a clinically actionable #biomarker to guide #EGFR rechallenge in metastatic #ColorectalCancer. Guillermo Argilés Martinez discusses positive #ClinicalTrial data with this selective approach.
#ESMODailyReporter 🔗 https://ow.ly/lnKi50Xiei7
#ESMODailyReporter 🔗 https://ow.ly/lnKi50Xiei7
October 27, 2025 at 4:02 PM
#ESMO25: #ctDNA has emerged as a clinically actionable #biomarker to guide #EGFR rechallenge in metastatic #ColorectalCancer. Guillermo Argilés Martinez discusses positive #ClinicalTrial data with this selective approach.
#ESMODailyReporter 🔗 https://ow.ly/lnKi50Xiei7
#ESMODailyReporter 🔗 https://ow.ly/lnKi50Xiei7
#ESMO25: Atezolizumab prolonged DFS in #ctDNA+ muscle-invasive #BladderCancer in the IMvigor011 #ClinicalTrial, providing first evidence in support of minimal residual disease-guided adjuvant #immunotherapy in this setting.
#ESMODailyReporter ➡️ https://ow.ly/ythW50XeYRP
#ESMODailyReporter ➡️ https://ow.ly/ythW50XeYRP
October 20, 2025 at 2:47 PM
#ESMO25: Atezolizumab prolonged DFS in #ctDNA+ muscle-invasive #BladderCancer in the IMvigor011 #ClinicalTrial, providing first evidence in support of minimal residual disease-guided adjuvant #immunotherapy in this setting.
#ESMODailyReporter ➡️ https://ow.ly/ythW50XeYRP
#ESMODailyReporter ➡️ https://ow.ly/ythW50XeYRP
#ESMO25: The #ADC sacituzumab tirumotecan significantly prolonged progression-free survival vs chemotherapy in EGFR-mutated #NSCLC following progression on EGFR #TKI in the OptiTROP-Lung04 #ClinicalTrial
#ESMODailyReporter ➡️ https://ow.ly/eYW250XeAhG
Antonio Passaro
#LungCancer
#ESMODailyReporter ➡️ https://ow.ly/eYW250XeAhG
Antonio Passaro
#LungCancer
October 19, 2025 at 3:15 PM
#ESMO25: The #ADC sacituzumab tirumotecan significantly prolonged progression-free survival vs chemotherapy in EGFR-mutated #NSCLC following progression on EGFR #TKI in the OptiTROP-Lung04 #ClinicalTrial
#ESMODailyReporter ➡️ https://ow.ly/eYW250XeAhG
Antonio Passaro
#LungCancer
#ESMODailyReporter ➡️ https://ow.ly/eYW250XeAhG
Antonio Passaro
#LungCancer
October 11, 2025 at 11:16 PM
#Medsky🧪 #Drugdevelopment #publichealth The experience of a participant in a #clinicaltrial for dengue would reflect the general phases of a drug trial, though specific procedures vary by the trial & the drug being tested.
'The next day, I went back to the facilities, where a nurse injected my arm with a genetically modified version of the DENV-3 serotype of the dengue virus designed to give only mild illness rather than full-blown “break-bone fever,” as the illness is known colloquially.'
cen.acs.org/pharmaceutic...
cen.acs.org/pharmaceutic...
I was injected with dengue virus to learn about clinical trials
I became a test subject in a clinical trial for a new dengue treatment. Here’s what I discovered
cen.acs.org
October 11, 2025 at 7:32 AM
#Medsky🧪 #Drugdevelopment #publichealth The experience of a participant in a #clinicaltrial for dengue would reflect the general phases of a drug trial, though specific procedures vary by the trial & the drug being tested.
🌿 Clinical trial participants taking cannabis extracts experienced greater short-term and long-term pain relief, as well as superior sleep quality. #NORML #marijuana #cannabis #clinicaltrial #backpain
Cannabis Extract Superior to Opioids for Chronic Back Pain
Clinical trial patients experienced greater short-term and long-term pain relief
norml.org
October 7, 2025 at 6:37 PM
🌿 Clinical trial participants taking cannabis extracts experienced greater short-term and long-term pain relief, as well as superior sleep quality. #NORML #marijuana #cannabis #clinicaltrial #backpain
October 3, 2025 at 9:09 PM
👏 1st Site Visit Completed for A-TANGO's #ClinicalTrial: Thanks to big efforts by Yaqrit + Royal Free Hospital, we have kicked off our Phase 2a trial, evaluating the safety of #TLR4 antagonist in combination with #G-CSF for the treatment of #ACLF!
#BenchToBedside #cirrhosis
@rajivjalan.bsky.social
#BenchToBedside #cirrhosis
@rajivjalan.bsky.social
October 4, 2025 at 5:03 AM
👏 1st Site Visit Completed for A-TANGO's #ClinicalTrial: Thanks to big efforts by Yaqrit + Royal Free Hospital, we have kicked off our Phase 2a trial, evaluating the safety of #TLR4 antagonist in combination with #G-CSF for the treatment of #ACLF!
#BenchToBedside #cirrhosis
@rajivjalan.bsky.social
#BenchToBedside #cirrhosis
@rajivjalan.bsky.social
My amazing client Tiffany Graham Charkosky has a piece in Oprah Daily today. As always, Tiffany writes with honesty and vulnerability, and I am so grateful to her for sharing her story with the world! www.oprahdaily.com/life/health/...
#cancer #genetictesting #clinicaltrial
#cancer #genetictesting #clinicaltrial
I Inherited a Deadly Cancer Gene—Now I’m Volunteering to Test a Vaccine That Could Save Generations
Could I fend off the disease that that took my mom when she was 31? It was worth a shot.
www.oprahdaily.com
September 30, 2025 at 3:12 PM
My amazing client Tiffany Graham Charkosky has a piece in Oprah Daily today. As always, Tiffany writes with honesty and vulnerability, and I am so grateful to her for sharing her story with the world! www.oprahdaily.com/life/health/...
#cancer #genetictesting #clinicaltrial
#cancer #genetictesting #clinicaltrial
JMIR Res Protocols: Evaluating the Effectiveness of a Multimodal Psychotherapy Training Program for Medical Students in China: #Protocol for a #RCT #ClinicalTrial
Evaluating the Effectiveness of a Multimodal Psychotherapy Training Program for Medical Students in China: #Protocol for a #RCT #ClinicalTrial
Background: Psychotherapy is central to the treatment of mental disorders, highlighting the importance of medical students and residents developing competencies in this area. Chinese medical residents have expressed a strong need for psychotherapy…
dlvr.it
January 3, 2025 at 1:39 PM
JMIR Res Protocols: Evaluating the Effectiveness of a Multimodal Psychotherapy Training Program for Medical Students in China: #Protocol for a #RCT #ClinicalTrial
The feasibility and effectiveness of smartwatch device on the adherence to the home-based cardiac rehabilitation in #Patients with coronary heart #Disease: A #RCT #ClinicalTrial. (preprint) #openscience #PeerReviewMe #PlanP
The feasibility and effectiveness of smartwatch device on the adherence to the home-based cardiac rehabilitation in #Patients with coronary heart #Disease: A #RCT #ClinicalTrial.
Date Submitted: Jan 5, 2025.
Open Peer Review Period: Jan 8, 2025 - Mar 5, 2025.
dlvr.it
January 8, 2025 at 1:28 PM
The feasibility and effectiveness of smartwatch device on the adherence to the home-based cardiac rehabilitation in #Patients with coronary heart #Disease: A #RCT #ClinicalTrial. (preprint) #openscience #PeerReviewMe #PlanP
Exciting progress in Parkinson's research! Early clinical trials of stem-cell therapy show promise in being safe for transplanting dopamine-releasing neurons.
www.nature.com/articles/d41...
#ClinicalTrial #ParkinsonsDisease #StemCellTherapy #MedicalResearch
www.nature.com/articles/d41...
#ClinicalTrial #ParkinsonsDisease #StemCellTherapy #MedicalResearch
Clinical trials test the safety of stem-cell therapy for Parkinson’s disease
Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson’s disease. Two clinical trials show that it is safe, but more evidence is needed to prove its ...
www.nature.com
April 17, 2025 at 2:44 PM
Exciting progress in Parkinson's research! Early clinical trials of stem-cell therapy show promise in being safe for transplanting dopamine-releasing neurons.
www.nature.com/articles/d41...
#ClinicalTrial #ParkinsonsDisease #StemCellTherapy #MedicalResearch
www.nature.com/articles/d41...
#ClinicalTrial #ParkinsonsDisease #StemCellTherapy #MedicalResearch
JMIR Res Protocols: Impact of the Mediterranean Diet on Patients With Psoriasis: #Protocol for a #RCT #ClinicalTrial
Impact of the Mediterranean Diet on Patients With Psoriasis: #Protocol for a #RCT #ClinicalTrial
Background: Psoriasis is an inflammatory disease primarily treated through molecular-targeted therapies. However, emerging evidence suggests that dietary interventions may also play a role in managing inflammation associated with this condition. The…
dlvr.it
January 29, 2025 at 7:44 PM
JMIR Res Protocols: Impact of the Mediterranean Diet on Patients With Psoriasis: #Protocol for a #RCT #ClinicalTrial
Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Prevent Job Loss in Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
December 22, 2024 at 10:55 AM
Assessing NHS ImplemeNTation of an onlinE Resilience Training Acceptance and Commitment Therapy (ACT) Programme to Prevent Job Loss in Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Improving Learning and Memory in Portuguese Patients With Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
December 23, 2024 at 12:44 PM
Improving Learning and Memory in Portuguese Patients With Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
These ideas need to be tested looking forwards, within a #clinicaltrial. Many countries like Australia would benefit from supporting these clinical trials as they could be immediately cost-saving, as well as potentially helping people live better and longer @anzuptrials.bsky.social
December 26, 2024 at 11:34 PM
These ideas need to be tested looking forwards, within a #clinicaltrial. Many countries like Australia would benefit from supporting these clinical trials as they could be immediately cost-saving, as well as potentially helping people live better and longer @anzuptrials.bsky.social
Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
June 18, 2024 at 6:55 AM
Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Clinical study of autologous neural stem cells to treat Alzheimer's disease
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
June 16, 2024 at 3:55 AM
Clinical study of autologous neural stem cells to treat Alzheimer's disease
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
Join us for an informative webinar discussing industry Best Practices in providing financial support for #clinicaltrial participants. Webinar is March 5, 2025 from 11 AM to 12:00 PM ET. Register here: us06web.zoom.us/webinar/regi...
February 12, 2025 at 4:18 PM
Join us for an informative webinar discussing industry Best Practices in providing financial support for #clinicaltrial participants. Webinar is March 5, 2025 from 11 AM to 12:00 PM ET. Register here: us06web.zoom.us/webinar/regi...
Semaglutide shows significant weight loss and health benefits in four-year obesity study 💊🏋️♀️📉 www.news-medical.net/news/2024051... #Obesity #WeightLoss #Health #Semaglutide #BMI #Diabetes #Cardiovascular #Health #ClinicalTrial @natureportfolio.bsky.social
Semaglutide shows significant weight loss and health benefits in four-year obesity study
A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health m...
www.news-medical.net
May 15, 2024 at 2:18 AM
Semaglutide shows significant weight loss and health benefits in four-year obesity study 💊🏋️♀️📉 www.news-medical.net/news/2024051... #Obesity #WeightLoss #Health #Semaglutide #BMI #Diabetes #Cardiovascular #Health #ClinicalTrial @natureportfolio.bsky.social
#MedSky🧪 #IDSky #pharmasky #publichealh This phase I&II #Clinicaltrial provides preliminary evidence supporting the Tx of #COVID19 patients with moderate/severe symptoms using NK from #COVID19 convalescent donors is feasible & safe.
www.cell.com/iscience/ful...
www.cell.com/iscience/pdf...
www.cell.com/iscience/ful...
www.cell.com/iscience/pdf...
December 29, 2024 at 8:21 PM
#MedSky🧪 #IDSky #pharmasky #publichealh This phase I&II #Clinicaltrial provides preliminary evidence supporting the Tx of #COVID19 patients with moderate/severe symptoms using NK from #COVID19 convalescent donors is feasible & safe.
www.cell.com/iscience/ful...
www.cell.com/iscience/pdf...
www.cell.com/iscience/ful...
www.cell.com/iscience/pdf...
No Evidence Of Disease Activity After Autologous Haematopoietic Stem Cell Transplantation In Aggressive Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
December 29, 2024 at 1:04 PM
No Evidence Of Disease Activity After Autologous Haematopoietic Stem Cell Transplantation In Aggressive Multiple Sclerosis
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS
#MSchat #Neurology #MultipleSclerosis #ClinicalTrial #botsFightMS